Autologous stem cell transplantation in primary systemic amyloidosis: the impact of selection criteria on outcome.
about
Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research StudyChronic diarrhea as the initial clinical manifestation of light-chain amyloidosis with cardiac involvement despite negative duodenal and rectal biopsies.An overview of high-dose melphalan and stem cell transplantation in the treatment of AL amyloidosis.Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patientsStem cell transplantation for mantle cell lymphoma: if, when and how?Autologous transplantation for primary systemic AL amyloidosis is feasible outside a major amyloidosis referral centre: the Calgary BMT Program experience.Multiple myeloma-associated AL amyloidosis: is a distinctive therapeutic approach warranted?Perspectives in treatment of AL amyloidosis.Current status of hematopoietic cell transplantation in the treatment of systemic amyloid light-chain amyloidosis.Role of high-dose melphalan and autologous peripheral blood stem cell transplantation in AL amyloidosis.Trends in day 100 and 2-year survival after auto-SCT for AL amyloidosis: outcomes before and after 2006.Osteopontin: a novel predictor of survival in patients with systemic light-chain amyloidosis.Troponin T level as an exclusion criterion for stem cell transplantation in light-chain amyloidosis.Living donor kidney and autologous stem cell transplantation for primary systemic amyloidosis (AL) with predominant renal involvement.Outcome of autologous stem cell transplantation for AL amyloidosis in the UK
P2860
Q30278687-86636B1A-D48D-4771-9466-1913A3AA941FQ33163149-8C4B5831-0030-4E9C-A91C-E5535AAA4E93Q33304297-CC8B4F67-3945-40F6-8596-088BDE9EC6CFQ35485742-21CCE0FB-6BDA-40EE-B634-851F48F52110Q36188687-6CCD1979-8311-4054-99D4-804AF80E08E5Q36215543-F652BBB3-CC2B-4D0D-A493-D65A4FB76688Q36484561-4BE6B186-5F83-4339-8CD3-56896B293789Q37045885-D910EAA2-50E8-4A92-8E0E-C31399C04211Q37904673-C292FB44-D00F-4D9C-A281-BC6681A3AB36Q37995198-8ECF1BBD-BBA6-4FFC-A92E-CDC5540076A9Q44468671-D9D44D7E-529E-4FDC-9C3B-4B9E84BB2AE0Q44657473-3D76BFD8-3D46-4A4D-80C6-0C2958C6EDE3Q53504425-0740F1DE-A9B6-499E-98D9-4C7AAAB6E1A7Q53671959-DCCF37B1-5E10-402A-9AF2-71576527904FQ58853185-BBB1C163-C0E6-4B17-A518-BD46563C946F
P2860
Autologous stem cell transplantation in primary systemic amyloidosis: the impact of selection criteria on outcome.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Autologous stem cell transplan ...... selection criteria on outcome.
@en
Autologous stem cell transplan ...... selection criteria on outcome.
@nl
type
label
Autologous stem cell transplan ...... selection criteria on outcome.
@en
Autologous stem cell transplan ...... selection criteria on outcome.
@nl
prefLabel
Autologous stem cell transplan ...... selection criteria on outcome.
@en
Autologous stem cell transplan ...... selection criteria on outcome.
@nl
P2093
P2860
P356
P1476
Autologous stem cell transplan ...... selection criteria on outcome.
@en
P2093
Pereira DL
Stewart AK
Wechalekar AD
P2860
P2888
P304
P356
10.1038/SJ.BMT.1704344
P407
P577
2004-02-01T00:00:00Z